Jan Moritz Middeke Selected Research

Jan Moritz Middeke Research Topics

8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 06/2016
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 06/2012
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2016
4	Neoplasms (Cancer) 01/2021 - 06/2016
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2021 - 10/2020
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 12/2018
2	Tumor Lysis Syndrome 01/2017 - 03/2014
1	Bronchiolitis Obliterans Syndrome 01/2021
1	Anemia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Inflammation (Inflammations) 10/2020
1	Leukemia 01/2020
1	Cytomegalovirus Infections (Inclusion Disease) 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Hyperuricemia 01/2017
1	Multiple Myeloma 11/2016
1	Paraproteinemias (Monoclonal Gammopathy) 02/2015
1	Scleromyxedema (Lichen Myxedematosus) 02/2015
1	Iron Overload 12/2012
1	Infections 06/2012

3	BI 836826IBA 02/2021 - 10/2020
2	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 12/2018
2	Clofarabine (Clolar)FDA Link 12/2017 - 06/2016
2	rasburicase (Elitek)FDA Link 01/2017 - 03/2014
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021
1	CPX-351IBA 10/2021
1	ruxolitinibIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	ChemokinesIBA 10/2020
1	Core Binding Factors (Core-Binding Factor)IBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	Urate Oxidase (Uricase)IBA 01/2017
1	purineIBA 06/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2016
1	Cytostatic AgentsIBA 06/2016
1	fludarabineIBA 01/2016
1	ofatumumab FDA Link 01/2016
1	MucinsIBA 02/2015
1	Interleukin-17 (Interleukin 17)IBA 03/2013
1	Biomarkers (Surrogate Marker)IBA 12/2012

7	Cell Transplantation 01/2022 - 03/2013
5	Therapeutics 06/2022 - 01/2016
5	Stem Cell Transplantation 01/2021 - 06/2012
2	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2017
2	Transplantation 01/2020 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2022
1	Salvage Therapy 01/2022